Search results for "Stroke"
Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds
Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.
https://immattersacp.org/weekly/archives/2022/10/18/2.htm
18 Oct 2022
CDC and FDA weigh in on safety of bivalent vaccine; research examines COVID-19 sequelae, omicron variants
The CDC and FDA said an observed association of ischemic stroke with the Pfizer-BioNTech bivalent booster is very unlikely to represent a true clinical risk. New studies reported on symptoms a year after mild COVID-19 and estimated protection against the omicron variants.
https://immattersacp.org/weekly/archives/2023/01/24/2.htm
24 Jan 2023
Lower systolic blood pressure target appears to improve outcomes in elderly patients without diabetes or stroke
Treating to lower systolic blood pressure targets in ambulatory adults ages 75 years and older led to better outcomes, specifically lower rates of all-cause mortality and cardiovascular events.
https://immattersacp.org/weekly/archives/2016/05/24/1.htm
24 May 2016
Risks and benefits of procedure versus medication in afib vary by individual
A modeling study found that left atrial appendage occlusion could be an alternative to oral anticoagulants in patients at high bleeding risk but that the combination of risks for stroke and bleeding should be considered on an individual basis.
https://immattersacp.org/weekly/archives/2022/08/16/4.htm
16 Aug 2022
MKSAP Quiz: Evaluation for worsening choking
A 75-year-old man is evaluated for choking that started 3 months ago and has progressively worsened. Parkinson disease was diagnosed 3 months ago. His only medication is carbidopa-levodopa. After physical examination, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2021/12/07/3.htm
7 Dec 2021
Kidney failure, CV events lower with canagliflozin than placebo, industry study finds
The trial was stopped early after an interim safety analysis found significantly better renal and cardiovascular outcomes among type 2 diabetes patients randomized to canagliflozin than those assigned to placebo.
https://immattersacp.org/weekly/archives/2019/04/23/2.htm
23 Apr 2019
Outcomes after TIA appear similar with outpatient vs. inpatient care
A systematic review and meta-analysis found that patients with transient ischemic attack (TIA) or minor ischemic stroke who were cared for at a TIA clinic had a similar risk for subsequent stroke as patients admitted to a hospital.
https://immattersacp.org/weekly/archives/2022/01/11/5.htm
11 Jan 2022
Amiodarone increases bleeding compared with flecainide or sotalol in patients on anticoagulant therapy
A retrospective analysis of Medicare patients who started an anticoagulant and then amiodarone found that they had a 44% increased risk for bleeding-related hospitalization compared to those on other antiarrhythmics and that this risk was higher with rivaroxaban than apixaban.
https://immattersacp.org/weekly/archives/2023/05/23/1.htm
23 May 2023
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022
MKSAP Quiz: Evaluation for episode of right arm weakness
A 49-year-old-man is evaluated 1 day after having an episode of right arm weakness without pain that lasted 5 minutes. He is now asymptomatic. Following a physical exam and electrocardiogram, what is the most appropriate initial imaging test?
https://immattersacp.org/weekly/archives/2019/08/13/3.htm
13 Aug 2019